We have shown that tumour promoter methylation within our target suppressor gene panel is commonly observed in familial and particularly BRCA2 male breast cancers suggesting aberrant hypermethylation may be a significant driver in MBCs carrying prognostic information. Here, BRCA2 is linked to breast carcinoma.